Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IFOSFAMIDE vs TEMOZOLOMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IFOSFAMIDE vs TEMOZOLOMIDE: Safety Overview

Metric IFOSFAMIDE TEMOZOLOMIDE
Total FAERS Reports 17,004 17,007
Deaths Reported 3,365 3,099
Death Rate 19.8% 18.2%
Hospitalizations 5,230 4,302
Average Patient Age 36.2 yrs 49.4 yrs
% Female Patients 41.7% 45.9%
FDA Approval Date Apr 4, 2007 Apr 12, 2016
Manufacturer Baxter Healthcare Corporation Rising Pharma Holdings, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued